New article: Coll2-1 and PRP injection
Artialis' biomarker and intra-articular injection of an autologous plasma-rich-platelet.
Coll2-1 in viscosupplementation: results form Epikart study
Artialis' biomarker Coll2-1 and viscosupplementation of hyaluronic acid: results from EPIKART, a Pilot Prospective Comparative Randomized Double Blind Trial.
New Job opportunity
Artialis is seeking for a Junior Administrative Assistante.
We wanted to know whether oral treatment with polyphenols could decreased serum level of OA biomarkers in DMM mice model and needed results quickly. [Artialis has offered] robust skills, reactivity, and possibility to academic collaboration.
PhD candidate, INSERM U791, Laboratoire d'Ingénierie Ostéo-Articulaire et Dentaire (France)
Since the biomarker world is very competitive, every work involving new biomarkers should be previously and accurately discussed to tune the interests of the Sponsor with those of Artialis.
They are on time and flexible [and have] the ability to focus rapidly on the Sponsor requirement.
[We appreciate the] reliability of data and the open and timely communication.
Director Pharmacology & Toxicology, Rottapharm Biotech
We needed a specific measure for the cartilage degeneration to prove the efficacy of our product. The collaboration with Artialis was a logical choice
Sales & Marketing Director, Tilman (Belgium)